Home > Qtrly Results > DIVIS LABORATORIES

DIVIS LABORATORIES
Quarterly Results Analysis [Dec2024]

DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for DIVIS LABORATORIES
Please provide your vote to see the results

DIVIS LABORATORIES Quarterly Results

Consolidated Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
Audited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Revenues ₹2,319 Cr ₹2,338 Cr ₹2,118 Cr ₹2,303 Cr ₹1,855 Cr ₹1,909 Cr ₹1,778 Cr ₹1,951 Cr
Expenses ₹1,576 Cr ₹1,622 Cr ₹1,496 Cr ₹1,572 Cr ₹1,366 Cr ₹1,430 Cr ₹1,274 Cr ₹1,464 Cr
Operating Income ₹743 Cr ₹716 Cr ₹622 Cr ₹731 Cr ₹489 Cr ₹479 Cr ₹504 Cr ₹487 Cr
Other Income ₹82 Cr ₹106 Cr ₹79 Cr ₹79 Cr ₹95 Cr ₹86 Cr ₹81 Cr ₹66 Cr
Interest ₹0 Cr ₹1 Cr ₹0 Cr ₹2 Cr ₹0 Cr ₹1 Cr ₹0 Cr ₹0 Cr
Depreciation ₹99 Cr ₹99 Cr ₹97 Cr ₹95 Cr ₹95 Cr ₹95 Cr ₹93 Cr ₹87 Cr
Profit Before Tax ₹726 Cr ₹722 Cr ₹604 Cr ₹713 Cr ₹489 Cr ₹469 Cr ₹492 Cr ₹466 Cr
Profit After Tax ₹589 Cr ₹510 Cr ₹430 Cr ₹538 Cr ₹358 Cr ₹348 Cr ₹356 Cr ₹321 Cr
EPS ₹22.23 ₹19.25 ₹16.23 ₹20.30 ₹13.51 ₹13.13 ₹13.43 ₹12.11
Industry Peers & Returns1W1M1Y
DIVIS LABORATORIES 4.3% 6.5% 63.9%
SUN PHARMACEUTICAL INDUSTRIES 0.6% -2.1% 16.5%
CIPLA 3.6% 0.2% 2.3%
DR REDDYS LABORATORIES 3% -8.4% 0%
ZYDUS LIFESCIENCES 3.2% -1% 27.4%
MANKIND PHARMA -2.5% -8% 16.5%
TORRENT PHARMACEUTICALS 2.9% -0.5% 19.4%
LUPIN 8.2% 0.4% 37%
AUROBINDO PHARMA 5.8% -0.7% 19.5%

DIVIS LABORATORIES Quarterly Revenues

Revenues
Q-o-Q

-0.81 %

Y-o-Y

25.01 %

Quarters Revenues % Change
Dec2024 ₹2,319 Cr
-0.81
Sep2024 ₹2,338 Cr
10.39
Jun2024 ₹2,118 Cr
-8.03
Mar2024 ₹2,303 Cr
24.15
Dec2023 ₹1,855 Cr
-2.83
Sep2023 ₹1,909 Cr
7.37
Jun2023 ₹1,778 Cr
-8.87
Mar2023 ₹1,951 Cr -

DIVIS LABORATORIES Quarterly Operating Profit

Operating Profit
Q-o-Q

3.77 %

Y-o-Y

51.94 %

Quarters Operating Profit % Change
Dec2024 ₹743 Cr
3.77
Sep2024 ₹716 Cr
15.11
Jun2024 ₹622 Cr
-14.91
Mar2024 ₹731 Cr
49.49
Dec2023 ₹489 Cr
2.09
Sep2023 ₹479 Cr
-4.96
Jun2023 ₹504 Cr
3.49
Mar2023 ₹487 Cr -
Operating Margins
Q-o-Q

4.64 %

Y-o-Y

21.55 %

Quarters Operating Margin% % Change
Dec2024 32.04%
4.64
Sep2024 30.62%
4.26
Jun2024 29.37%
-7.47
Mar2024 31.74%
20.41
Dec2023 26.36%
5.06
Sep2023 25.09%
-11.50
Jun2023 28.35%
13.58
Mar2023 24.96% -

DIVIS LABORATORIES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

15.49 %

Y-o-Y

64.53 %

Quarters Profit After Tax % Change
Dec2024 ₹589 Cr
15.49
Sep2024 ₹510 Cr
18.60
Jun2024 ₹430 Cr
-20.07
Mar2024 ₹538 Cr
50.28
Dec2023 ₹358 Cr
2.87
Sep2023 ₹348 Cr
-2.25
Jun2023 ₹356 Cr
10.90
Mar2023 ₹321 Cr -
PAT Margins
Q-o-Q

16.46 %

Y-o-Y

31.61 %

Quarters PAT Margin(%) % Change
Dec2024 25.4 %
16.46
Sep2024 21.81 %
7.44
Jun2024 20.3 %
-13.10
Mar2024 23.36 %
21.04
Dec2023 19.3 %
5.87
Sep2023 18.23 %
-8.94
Jun2023 20.02 %
21.70
Mar2023 16.45 % -

DIVIS LABORATORIES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

15.48 %

Y-o-Y

64.54 %

Quarters EPS % Change
Dec2024 ₹22.23
15.48
Sep2024 ₹19.25
18.61
Jun2024 ₹16.23
-20.05
Mar2024 ₹20.3
50.26
Dec2023 ₹13.51
2.89
Sep2023 ₹13.13
-2.23
Jun2023 ₹13.43
10.90
Mar2023 ₹12.11 -

You may also like the below Video Courses